Sosei R&D Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sosei R&D Ltd. - overview
Location
-, -, UK
Primary Industry
Pharmaceuticals
About
Arakis is a UK-based company that operates as a provider of pharmaceutical products.
Current Investors
Excalibur Fund Managers, MB Venture Partners, 3i
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Sosei R&D Ltd. - financials
| Fiscal Year Ended | Mar 31, 2009 | Mar 31, 2010 | Mar 31, 2011 | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 195,963.806 | 7,369,651.556 | 8,503,527.603 | 4,916,878.726 | 17,505,236.87 | 17,087,335.25 | 35,383,074.456 | - | - | - |
| % Revenue Growth (YoY) | - | 3660.7% | 15.4% | (42.2%) | 256.0% | (2.4%) | 107.1% | - | - | - |
| EBITDA (USD) | (17,531,884.676) | 4,829,548.517 | 5,705,843.681 | 3,036,332.252 | 17,694,875.619 | 9,256,037.455 | 31,452,876.076 | - | - | - |
| Operating Income (USD) | (18,922,540.104) | 4,685,859.47 | 5,634,267.786 | 2,975,669.463 | 17,664,849.483 | 9,254,447.343 | 31,451,263.356 | - | - | - |
| Operating Margin | (9656.1%) | 63.6% | 66.3% | 60.5% | 100.9% | 54.2% | 88.9% | - | - | - |
| % EBITDA Margin | (8946.5%) | 65.5% | 67.1% | 61.8% | 101.1% | 54.2% | 88.9% | - | - | - |
| NET Income (USD) | (18,489,356.954) | 4,347,391.938 | 5,525,347.945 | 6,074,260.894 | 18,094,697.315 | 13,746,511.561 | 25,637,408.141 | - | - | - |
| % Net Margin | (9435.1%) | 59.0% | 65.0% | 123.5% | 103.4% | 80.4% | 72.5% | - | - | - |
Sosei R&D Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Sosei R&D Ltd. | - | ||||||||
| Series C | Completed | Sosei R&D Ltd. | - | ||||||||
| Series B | Completed | Sosei R&D Ltd. | - | ||||||||
| Unspecified Round | Completed | Sosei R&D Ltd. | - |
Displaying 1 - 4 of 4
Sosei R&D Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.